SCHEMBL7927941

SCHEMBL7927941

C/C=C/c1nc2ccccc2cc1C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.52
PDE10A Q9Y233 1/20 0.49
ALDH1A1 P00352 3/20 0.45
HPGD P15428 3/20 0.45
MAPT P10636 3/20 0.45
GLA P06280 1/20 0.45
ACHE P22303 1/20 0.45
MBNL1 Q9NR56 1/20 0.44
KDM4E B2RXH2 4/20 0.43
STAT3 P40763 2/20 0.43
GAA P10253 1/20 0.43
NQO2 P16083 1/20 0.41
CYP1A2 P05177 3/20 0.40
RAB9A P51151 3/20 0.37
NPC1 O15118 2/20 0.37
POLB P06746 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TLR8 Q9NR97 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14911814 0.85 TDP1 (0.56) TDP1PDE10AALDH1A1HPGDMAPT
SCHEMBL14911816 0.85 TDP1 (0.56) TDP1PDE10AALDH1A1HPGDMAPT
SCHEMBL14911960 0.79 TDP1 (0.53) TDP1PDE10AALDH1A1HPGDMAPT
SCHEMBL23430686 0.77 TLR8 (0.43) TDP1ALDH1A1HPGDMAPTGLA
SCHEMBL12948126 0.77 ALDH1A1 (0.41) TDP1PDE10AALDH1A1HPGDMAPT
SCHEMBL12409538 0.76 ALDH1A1 (0.39) TDP1PDE10AALDH1A1HPGDMAPT
SCHEMBL7927833 0.75 PDE10A (0.48) PDE10AALDH1A1HPGDMAPTKDM4E
SCHEMBL12708285 0.75 PDE10A (0.48) PDE10AALDH1A1HPGDMAPTKDM4E
SCHEMBL12646554 0.74 ALDH1A1 (0.41) TDP1PDE10AALDH1A1HPGDMAPT
SCHEMBL422035 0.71 ALDH1A1 (0.63) TDP1PDE10AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2342191-B1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORP (JP) 2013-03-20 EP disclosed
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-07 US disclosed
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-07-07 US disclosed
US-20110160206-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-06-30 US disclosed
US-20110160206-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-06-30 US disclosed
WO-2010030027-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-18 WO disclosed
WO-2010027097-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166135-A1 AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE PDE10A, PDE3A, PDE3B TDP1 998/4885PDE10A 1/4885ALDH1A1 1520/4885
US-20110160206-A1 TRI-SUBSTITUTED PYRIMIDINE COMPOUNDS AND THEIR USE AS PDE10 INHIBITORS PDE10A, PDE12, PDE9A TDP1 127/4885PDE10A 1/4885ALDH1A1 866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.